Keywords

• 936563-96-1
• Ibrutinib
• Ibrutinib Powder

Quick Details

• ProName: Pharmaceutical Manufacturing Bulk Pure...
• CasNo: 936563-96-1
• Molecular Formula: C25H24N6O2
• Appearance: White powder
• Application: Ibrutinib is a kind of Bruton tyrosine...
• DeliveryTime: 3-5 days
• PackAge: 1-5kg Bag 5-25kg Carton 25kg Drum
• Port: Shanghai,China
• ProductionCapacity: 5000 Kilogram/Month
• Purity: 99%
• Storage: Cool Dry Place
• Transportation: 25KG/drum,or according to your require...
• LimitNum: 100 Gram
• Related Substances: ≥98%
• Residue on Ignition: ≤0.1%
• Heavy Metal: ≤0.1%
• Valid Period: 2 years
• Grade Standard: Pharmaceutical grade
• Test Method: HPLC UV
• Place of Origin: Xi‘an,China
• Purity: 99%
• State: Solid
• MF: C25H24N6O2
• Storage: Cool Dry Place
• Shelf Life: 2years
• Transport Package: Bag/Drum

Superiority

We promise our customer following items:

1.Support product customization:

We can provide OEM&ODM , Because we have a professional design team


2.Reasonable price:
We provide high quality products with competitive price in china,

3.Low moq:
No worry about the low moq, our moq is 1 gram or lower.

3.Good and efficient service,Fast Delivery
Fast respond save client's time, we promise to reply inquiry in 24 hours including holidays and send quotation sheet and other documents in 48 hours.

4.Super-good quality
We have strict quality control system .Good reputation in Market , And have the Third party test report is available


Pls contact us

If you have any further questions or need a sample,Please do not hesitate to contact us.

Xi'an Julong Bio-Tech Co., Ltd.

Details

                                                      Pharmaceutical Manufacturing Bulk 99% Pure CAS 936563-96-1 Ibrutinib Powder Price

Ibrutinib is a kind of Bruton tyrosine kinase (BTK) inhibitor, it could be used for the treatment of chronic lymphocytic leukemia (CLL) and
mantle cell lymphoma (MCL). MCL and CLL are belonged to the B-cell non-Hodgkin's lymphoma, which is difficult to cure and easy to
recurrent. Common chemical immunotherapy does not have the targeting, often occurs 3 or 4 adverse reactions. Ibrutinib and B lymphocytes
could target with BTK which is necessary for formation, differentiation, and transmission of information, inhibit BTK activity irreversibly,
and inhibit tumor cell proliferation and survival effectively. Ibrutinib could be rapidly absorbed after oral administration, during 1~2h reach
maximum blood concentration, adverse reactions belong to one or two, therefore, Ibrutinib will become a new choice of treatment of CLL and
MCL.

Julong Bio-Tech Co., Ltd. is located in Xi'an City, Shaanxi Province, China. It is a biotechnology enterprise engaged in the research, development,production and sales of
animal and plant extracts, cosmetics, pharmaceutical raw materials and intermediates. The company has complete experimental facilities. And advanced testing instruments
ensure the stability of product quality from all aspects. The company has a complete sales service system, the products are exported to countries all over the world, and have
won a good international reputation with excellent quality and excellent service.

The company has been adhering to the basic principles of "integrity, quality, service, and win-win" to serve customers, constantly strict requirements, set goals, and implement
win-win development.